Arab Finance: Memphis Pharmaceutical and Chemical Industries reported a 4% year-on-year plunge in net profits after tax in the fiscal year (FY) 2025/2026, according to the firm’s financial indicators.
The company recorded EGP 483.868 million in net profits after tax last FY, down from EGP 505.280 million during FY 2024/2025.
Meanwhile, revenues grew 13% to EGP 1.705 billion from EGP 1.507 billion.
Memphis is one of the oldest pharmaceutical and chemical companies in the Middle East and has been in the market since 1940.